To view this email as a web page, click here.

 
Treatments for actinic keratosis
 
Risk-factors for actinic keratosis 12-month turnover
Identifying associations with actinic keratosis variability instead of prevalence can be used to closely monitor organ transplant recipients at increased risk of developing actinic keratosis, researchers say. Learn more.
 
Predictors for successful actinic keratosis treatment
Strong predictors for achieving a favorable actinic keratosis treatment response from ingenol mebutate 0.015% gel are dermoscopic detection of red pseudonetwork lesions and facial location, a study shows. Learn more.
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.